Ładuje się......
From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?
Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market...
Zapisane w:
| Wydane w: | Vaccines (Basel) |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712259/ https://ncbi.nlm.nih.gov/pubmed/33050484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040597 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|